Insilico Medicine, Inc., a Baltimore-based next-generation artificial intelligence company specializing in the application of deep learning for drug discovery, announces that Juvenescence.AI, its joint venture with Juvenescence Limited, has licensed its first compound family for clinical development.
- Tips to help control oily skin May 25, 2018
- Why medicine leads the professions in suicide, and what we can do about it May 25, 2018
- Closed Cars Can Become Deathly Hot in Minutes May 24, 2018
- Tips to help control oily skin May 23, 2018
- HIV lies dormant in brain, increasing risk of dementia, but how? May 23, 2018
- ‘Pizza Challenge’ Suggests Food Is Just More Tempting to Some May 23, 2018